These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21425634)

  • 21. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident".
    Bertazzi PA; Zocchetti C; Guercilena S; Consonni D; Tironi A; Landi MT; Pesatori AC
    Epidemiology; 1997 Nov; 8(6):646-52. PubMed ID: 9345664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality of US pentachlorophenol production workers through 2005.
    Ruder AM; Yiin JH
    Chemosphere; 2011 Apr; 83(6):851-61. PubMed ID: 21440286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dioxin and cancer: a critical review.
    Cole P; Trichopoulos D; Pastides H; Starr T; Mandel JS
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):378-88. PubMed ID: 14623487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk assessment of dioxins and dioxin-like PCBs in food--comments by the German Federal Environmental Agency.
    Gies A; Neumeier G; Rappolder M; Konietzka R
    Chemosphere; 2007 Apr; 67(9):S344-9. PubMed ID: 17223171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
    Davis BJ; Mccurdy EA; Miller BD; Lucier GW; Tritscher AM
    Cancer Res; 2000 Oct; 60(19):5414-9. PubMed ID: 11034082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of epidemiology data to assess the cancer risk of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Tollefson L
    Regul Toxicol Pharmacol; 1991 Apr; 13(2):150-69. PubMed ID: 1852927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Steenland K; Piacitelli L; Deddens J; Fingerhut M; Chang LI
    J Natl Cancer Inst; 1999 May; 91(9):779-86. PubMed ID: 10328108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessments of polychlorinated dibenzo- p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food.
    Larsen JC
    Mol Nutr Food Res; 2006 Oct; 50(10):885-96. PubMed ID: 17009211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD); "dioxin".
    National Toxicology Program
    Rep Carcinog; 2002; 10():224-6. PubMed ID: 15340981
    [No Abstract]   [Full Text] [Related]  

  • 31. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD); "dioxin".
    Rep Carcinog; 2004; 11():III241-3. PubMed ID: 21089963
    [No Abstract]   [Full Text] [Related]  

  • 32. Risk assessment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on an epidemiologic study.
    Steenland K; Deddens J; Piacitelli L
    Am J Epidemiol; 2001 Sep; 154(5):451-8. PubMed ID: 11532787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCDD and cancer: a critical review of epidemiologic studies.
    Boffetta P; Mundt KA; Adami HO; Cole P; Mandel JS
    Crit Rev Toxicol; 2011 Aug; 41(7):622-36. PubMed ID: 21718216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dioxin--an analysis of the major human studies: comparison with animal-based cancer risks.
    Scheuplein RJ; Bowers JC
    Risk Anal; 1995 Jun; 15(3):319-33. PubMed ID: 7604166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Science policy choices and the estimation of cancer risk associated with exposure to TCDD.
    Gough M
    Risk Anal; 1988 Sep; 8(3):337-42. PubMed ID: 2849149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dioxin exposure and cancer risk in the Seveso Women's Health Study.
    Warner M; Mocarelli P; Samuels S; Needham L; Brambilla P; Eskenazi B
    Environ Health Perspect; 2011 Dec; 119(12):1700-5. PubMed ID: 21810551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context.
    Aylward LL; Lakind JS; Hays SM
    J Toxicol Environ Health A; 2008; 71(22):1499-508. PubMed ID: 18836925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer incidence and mortality in a New Zealand community potentially exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin from 2,4,5-trichlorophenoxyacetic acid manufacture.
    Read D; Wright C; Weinstein P; Borman B
    Aust N Z J Public Health; 2007 Feb; 31(1):13-8. PubMed ID: 17333602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in the environment: human health risk estimation and its application to the Seveso case as an example.
    di Domenico A; Zapponi GA
    Regul Toxicol Pharmacol; 1986 Sep; 6(3):248-60. PubMed ID: 3775083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.